Dublin, January 31, 2023 /PRNewswire/ — “European Small Molecule Contract Development and Manufacturing Organizations Market 2021-2031 by Product Type, Service Type, Customer Type, Therapeutic Area, and Country: Trend Forecasts and Growth Opportunities” report added of ResearchAndMarkets.com Recruitment.
Europe Small molecule contract development and manufacturing organization (CDMOs) market valued by $17.3406 billion It will increase in 2021 and grow by 6.2% annually from 2021 to 2031.
The market is driven by increasing demand for small molecule drugs and therapeutics, increasing demand for cost control in drug development, increasing incidence of disease, and rising healthcare costs.
In-depth analysis and assessments are generated from premium primary and secondary sources of information with input from industry experts across the value chain. This report is based on research from 2019 to 2021 and provides forecasts from 2022 to 2031 with 2021 as the baseline. (Note: Since the report is updated before delivery, the most recent year in the past is the base year and the forecast covers at least five years from the base year.)
trends and prospects Europe Markets are COVID-19 and Russia–Ukraine Conflict.
The report also covers the current competitive scenario and projected trends. It also presents key vendors, including market leaders and important start-ups.
Key Players Selected:
- Boehringer Ingelheim
- Cambrex Co., Ltd.
- Catalent
- Cipla
- Covance Corporation
- Lonza Group Co., Ltd.
- Medley Pharmaceutical
- Natoco Pharma
- Patheon (Thermo Fisher Scientific, Inc.)
- Piramal Pharma Solutions
- red hill biopharma
- Siegfried Holding AG
- Star Pharmaceutical
- Sun Pharmaceutical
- Teva
A detailed qualitative analysis includes identifying and investigating the following aspects:
- market structure
- growth driver
- constraints and challenges
- Emerging product trends and market opportunities
- Porters Fiber Force
Reporting scope
Active Pharmaceutical Ingredients (API)
- branded drugs
- generic drug
Finished Dosage Form (FDF)
- oral solid medicine
- injection drug
- semi-solid or liquid medicinal products
- Other FDFs
Based on service type
- Preclinical use
- clinical use
- Phase I
- Phase II
- Phase III
- Phase IV
- commercial use
By customer type
- Pharmaceutical company
- biotechnology companies
By therapeutic area
- Infection
- Oncology
- Ophthalmology
- cardiovascular disease
- central nervous system
- respiratory disease
- metabolic disease
- Other therapeutic areas
Geographically, the following national/regional markets have been fully explored:
- Germany
- England
- France
- Spain
- Italy
- Netherlands
- Remaining Europe (Further subdivided Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, DenmarkWhen Finland)
For more information on this report, please visit https://www.researchandmarkets.com/r/e853cn-small?w=5.
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. It provides up-to-date data on international and regional markets, key industries, top companies, new products and latest trends.
Media contact:
research and market
Laura WoodSenior Manager
[email protected]
For EST office hours, please call +1-917-300-0470.
US/Canada Toll Free +1-800-526-8630
For GMT office hours, please call +353-1-416-8900.
US Fax: 646-607-1904
Fax (outside US): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Market
